| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.098 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |